Gli Istituti Clinici Scientifici Maugeri sono degli istituti clinici operanti in Italia e riconosciuti come IRCCS.

During the past decade, Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica" are "Breast Cancer" (5 trials) and "Carcinoma, Renal Cell" (1 trials). Many other conditions were trialed in "Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (3 trials), "Docetaxel" (2 trials), "Doxorubicin" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".